Articles, insights, and posts about Child Development, early detection, and new methods in diagnosis and treatment.
El Dr. Pablo Videla habla sobre la Pediatrician View, la nueva tecnología desarrollada por FDNA. Este nuevo algoritmo permite a los pediatras especialistas recibir una pauta sobre el nivel de dismorfología facial que puede tener un paciente, lo cual puede ser fundamental en la decisión de derivar al paciente para un estudio de diagnóstico genético. […]
Check out now the recording of the webinar that took place on June 3rd, 2022 about matching ultra-rare cases in the clinic. On the first video, Dr Karen Gripp talks about the use of the GestaltMatcher algorithm in Face2Gene CLINIC. On part 2, Prof Peter Krawitz dives into the technology that makes this possible. Follow […]
The world is bearing witness to a technological revolution that fundamentally changes how we do everything from creating music, to driving a car, and even online shopping. Opinions of AI vary as to whether the technology is an actual benefit to the world as a whole or a potential threat to personal and national security. […]
Note: This talk was presented at the 2018 ACMG annual meeting. The video can be seen below, or at this link> Dr. Christine Stanley, Head of Clinical Laboratory for WuXi NextCODE, US and CLIA medical director for Q&A Diagnostics, discusses next-generation phenotyping for improved variant interpretation through integration of Face2Gene LABS with WuXi NextCODE’s variant interpretation […]
Note: This talk was presented at the 2018 ACMG annual meeting. The video can be seen below, or at this link> HISTORY Since the 1960s, the field of medical genetics has been evolving rapidly with regard to phenotype delineation and analysis. A disease phenotype requires a multi-faceted analysis. Besides defining the phenotype with diagnostic criteria, […]
Note: This talk was presented at the 2018 ACMG annual meeting. The video can be seen below, or at this link> Starting in 1996, a select few clinicians began identifying a small group of patients with similar phenotypic features: Down-syndrome-like facial features, short stature, intellectual disability, cataracts and sensorineural hearing loss. Among these clinicians was […]
FDNA’s CEO, Dekel Gelbman, joined two distinguished members of the genetics community—Dr. John Carey (University of Utah) and Dr. Christine Stanley (WuXi NextCODE)—on redefining phenotyping for clinical advancements and variant prioritization. Dr. Carey. a highly-practiced clinician, currently at the University of Utah’s Department of Medical Genetics, kicked off the webinar with a comprehensive background on […]
HIMSS Conference, Microsoft booth Thursday, March 7 3:40 PM PST Las Vegas, Nevada As over 40,000 health IT professionals, clinicians, executives, and vendors from around the world gather at this year’s HIMSS Annual Conference & Exhibition, speaker Anthony Antonuccio, VP of Product at FDNA shares FDNA’s experience with one of the leading clinics, Greenwood Genetic […]
English | Spanish In a packed auditorium at Mexico City’s CENTRO University, FDNA’s Senior Director of Marketing, Jeff Daniels, announced the launch of the Genomics Collaborative. This initiative prompts clinicians, patients, advocates and researchers to join forces in an effort to accelerate breakthroughs in precision medicine. The Genomics Collaborative allows participants to access FDNA’s deep […]